Ohio Pharmacy Law Complete Practice Test 2026

Qsymia is a medication that combines two active ingredients: phentermine and topiramate in an extended-release formulation. This combination is specifically designed for weight management in patients who are obese or overweight and have related health conditions. Phentermine is an appetite suppressant, while topiramate is primarily used as an anticonvulsant but has been found to also aid in weight loss by promoting feelings of fullness and reducing appetite.

The extended-release formulation is significant because it allows for a more gradual release of the medication into the body, leading to more stable blood levels and potentially reducing side effects. This combination leverages the benefits of both drugs to provide a more effective approach to weight management than either ingredient alone.

Other options that only mention phentermine or topiramate individually do not capture the full therapeutic intent of Qsymia, which relies on the synergistic effects of both compounds working together in a single formulation. The choice referencing "phenetamine" does not correspond to an actual drug approved for use, making it incorrect in this context.